MDM2 and cancer: In contrast with previous in vitro functional assays and some population-based studies, in which the T allele of rs2279744 was associated with decreased expression levels of MDM2 and decreased risk for cancer [12], [19], the present study showed that the TT genotype of rs2279744 was associated with increased risk of SGC.